[Pharmacokinetics and pharmacodynamics of vecuronium in children]

Area of Science:

• Pharmacology
• Pediatric Anesthesiology
• Neuromuscular Pharmacology

Background:

• Vecuronium is a neuromuscular blocking agent used in pediatric anesthesia.
• Understanding its pharmacodynamics and pharmacokinetics in children is crucial for safe and effective use.
• Previous studies have indicated potential differences in drug response between pediatric and adult populations.

Purpose of the Study:

• To investigate the pharmacodynamics of vecuronium in children aged 1 to 10 years.
• To establish the pharmacokinetics of vecuronium at a dose of 0.1 mg/kg in pediatric patients.
• To compare the dose-effect relationship and duration of action between children and adults.

Main Methods:

• Administered vecuronium doses ranging from 0.015 to 0.1 mg/kg to pediatric patients.
• Assessed neuromuscular blockade using mechanical measurements and electromyography.
• Determined pharmacokinetic parameters, including volume of distribution and plasma clearance, for a 0.1 mg/kg dose.

Main Results:

• Identified a smaller volume of distribution and higher plasma clearance of vecuronium in children compared to adults.
• Found that the dose-effect ratio for vecuronium was consistent between pediatric and adult patients.
• Observed a shorter duration of action of vecuronium in children than in adults.

Conclusions:

• Vecuronium exhibits distinct pharmacokinetic properties in children, characterized by a smaller distribution volume and increased plasma clearance.
• Despite pharmacokinetic differences, the dose-effect relationship of vecuronium remains similar in children and adults.
• The neuromuscular blockade induced by vecuronium is of shorter duration in pediatric patients, necessitating potential adjustments in dosing or monitoring strategies.